Recorded on site at the ASGCT 2026 Annual Meeting in Boston, this mini-series introduces listeners to ASGCT members and the work driving progress across the cell and gene therapy field. In each episode, members are invited to share their backgrounds, discuss the current state of the field, and reflect on the value of ASGCT membership. This series of brief, engaging conversations will help listeners get to know the people, perspectives, and ideas shaping the ASGCT community.
In this episode, host Ben McLeod of the ASGCT Communications Committee sits down with Chrissy Green, the co-founder and president of Finding Hope for Frizzle (FRRS1L). As a patient advocate, Chrissy discusses how her parent-led organization is working to develop a treatment for FRRS1L. In addition, she shares how the ASGCT Annual Meeting has given her access to individuals and organizations who can help with the development of the treatment.
Music: 'Origami' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.au

Development of a secretable frataxin for Friedrich’s ataxia with Dr. Dan DuBreuil
19:48

Member Minutes: Mark Deehan, PhD
06:28

A CFTR mRNA isoform for the treatment of 3’ CFTR PTC variants with Normand Allaire
40:23